Antitrust Antitrust

Twin UK drug-pricing antitrust appeals to be heard separately, judge rules

By Simon Zekaria
  • 21 Jan 2022 12:18
  • 21 Jan 2022 12:18
Appeals by Allergan, Advanz Pharma, other drugmakers and two private equity firms against UK decisions over anticompetitive drug pricing and market sharing will be heard in separate batches, a judge has ruled.

The Competition Appeal Tribunal today sought to iron out hearing schedules for the appeals, which focus on two decisions by

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News